Genome-wide association studies in type 1 diabetes, inflammatory bowel disease and other immune-mediated disorders

Seminars in Immunology

Volumn 21, Issue 6, 2009, Pages 355-362

  Hakonarson, Hakon ^a,b   Grant, Struan F A ^a,b  

^a the Joseph Stokes Jr Research Institute   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Genome wide association; Inflammatory bowel disease; Type 1 diabetes

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CATHEPSIN H; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 2; INSULIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN KINASE C THETA;

ASTHMA; CROHN DISEASE; ENTERITIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATORY BOWEL DISEASES;

EID: 70749128610     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2009.06.001     Document Type: Review

References (129)

1. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genetics 33 2 (2003) 177-182
2. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nature Reviews 6 2 (2005) 95-108
3. Carlson C.S., Eberle M.A., Kruglyak L., and Nickerson D.A. Mapping complex disease loci in whole-genome association studies. Nature 429 6990 (2004) 446-452
4. The International HapMap Project. Nature 426 6968 (2003) 789-796
5. A haplotype map of the human genome. Nature 437 7063 (2005) 1299-1320
6. Steemers F.J., Chang W., Lee G., et al. Whole-genome genotyping with the single-base extension assay. Nature Methods 3 1 (2006) 31-33
7. Gunderson K.L., Steemers F.J., Lee G., Mendoza L.G., and Chee M.S. A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genetics 37 5 (2005) 549-554
8. Reich D., Patterson N., De Jager P.L., et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nature Genetics 37 10 (2005) 1113-1118
9. Palmer L.J., and Cardon L.R. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366 9492 (2005) 1223-1234
10. Hattersley A.T., and McCarthy M.I. What makes a good genetic association study?. Lancet 366 9493 (2005) 1315-1323
11. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nature Reviews 2 2 (2001) 91-99
12. Cordell H.J., and Clayton D.G. Genetic association studies. Lancet 366 9491 (2005) 1121-1131
13. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 5720 (2005) 385-389
14. Edwards A.O., Ritter III R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 5720 (2005) 421-424
15. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 5720 (2005) 419-421
16. Thorleifsson G., Magnusson K.P., Sulem P., et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317 5843 (2007) 1397-1400
17. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 7130 (2007) 881-885
18. Wellcome Trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447 7145 (2007) 661-678
19. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 5829 (2007) 1331-1336
20. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 5829 (2007) 1336-1341
21. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 5829 (2007) 1341-1345
22. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genetics 39 6 (2007) 770-775
23. Salonen J.T., Uimari P., Aalto J.M., et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen Consortium. American Journal of Human Genetics 81 2 (2007) 338-345
24. Florez J.C., Manning A.K., Dupuis J., et al. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 56 12 (2007) 3063-3074
25. Hanson R.L., Bogardus C., Duggan D., et al. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56 12 (2007) 3045-3052
26. Rampersaud E., Damcott C.M., Fu M., et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56 12 (2007) 3053-3062
27. Hayes M.G., Pluzhnikov A., Miyake K., et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 56 12 (2007) 3033-3044
28. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 5830 (2007) 1491-1493
29. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 5830 (2007) 1488-1491
30. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448 7151 (2007) 353-357
31. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genetics 40 2 (2008) 189-197
32. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nature Genetics 40 2 (2008) 161-169
33. Kooner J.S., Chambers J.C., Aguilar-Salinas C.A., et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nature Genetics 40 2 (2008) 149-151
34. Gudmundsson J., Sulem P., Manolescu A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nature Genetics 39 5 (2007) 631-637
35. Yeager M., Orr N., Hayes R.B., et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature Genetics 39 5 (2007) 645-649
36. Haiman C.A., Patterson N., Freedman M.L., et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nature Genetics 39 5 (2007) 638-644
37. Tomlinson I., Webb E., Carvajal-Carmona L., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nature Genetics 39 8 (2007) 984-988
38. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 7148 (2007) 1087-1093
39. Stacey S.N., Manolescu A., Sulem P., et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nature Genetics 39 7 (2007) 865-869
40. Maris J.M., Mosse Y.P., Bradfield J.P., et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. The New England Journal of Medicine 358 24 (2008) 2585-2593
41. Wang K., Zhang H., Ma D., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009)
42. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355 9207 (2000) 873-876
43. Onkamo P., Vaananen S., Karvonen M., and Tuomilehto J. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42 12 (1999) 1395-1403
44. Bell G.I., Horita S., and Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33 2 (1984) 176-183
45. Bennett S.T., Lucassen A.M., Gough S.C., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genetics 9 3 (1995) 284-292
46. Vafiadis P., Bennett S.T., Todd J.A., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genetics 15 3 (1997) 289-292
47. Barratt B.J., Payne F., Lowe C.E., et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53 7 (2004) 1884-1889
48. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity?. Genes and Immunity 1 3 (2000) 170-184
49. Ueda H., Howson J.M., Esposito L., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 6939 (2003) 506-511
50. Anjos S.M., Tessier M.C., and Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. The Journal of Clinical Endocrinology and Metabolism 89 12 (2004) 6257-6265
51. Nistico L., Buzzetti R., Pritchard L.E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Human Molecular Genetics 5 7 (1996) 1075-1080
52. Bottini N., Musumeci L., Alonso A., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics 36 4 (2004) 337-338
53. Smyth D., Cooper J.D., Collins J.E., et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 11 (2004) 3020-3023
54. Vella A., Cooper J.D., Lowe C.E., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. American Journal of Human Genetics 76 5 (2005) 773-779
55. Qu H.Q., Montpetit A., Ge B., Hudson T.J., and Polychronakos C. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56 4 (2007) 1174-1176
56. Lowe C.E., Cooper J.D., Brusko T., et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nature Genetics 39 9 (2007) 1074-1082
57. Guo D., Li M., Zhang Y., et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics 36 8 (2004) 837-841
58. Mirel D.B., Valdes A.M., Lazzeroni L.C., et al. Association of IL4R haplotypes with type 1 diabetes. Diabetes 51 11 (2002) 3336-3341
59. Biason-Lauber A., Boehm B., Lang-Muritano M., et al. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48 5 (2005) 900-905
60. Smyth D.J., Cooper J.D., Bailey R., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nature Genetics 38 6 (2006) 617-619
61. Knip M., Veijola R., Virtanen S.M., et al. Environmental triggers and determinants of type 1 diabetes. Diabetes 54 Suppl. 2 (2005) S125-S136
62. Hakonarson H., Grant S.F., Bradfield J.P., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448 7153 (2007) 591-594
63. Finn R.D., Mistry J., Schuster-Bockler B., et al. Pfam: clans, web tools and services. Nucleic Acids Research 34 Database issue (2006) D247-251
64. Cambi A., and Figdor C.G. Levels of complexity in pathogen recognition by C-type lectins. Current Opinion in Immunology 17 4 (2005) 345-351
65. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 39 7 (2007) 857-864
66. Hakonarson H., Qu H.Q., Bradfield J.P., et al. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 57 4 (2008) 1143-1146
67. Grant S.F., Qu H.Q., Bradfield J.P., et al. Follow up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes (2008)
68. Concannon P., Onengut-Gumuscu S., Todd J.A., et al. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 57 10 (2008) 2858-2861
69. Cooper J.D., Smyth D.J., Smiles A.M., et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nature Genetics 40 12 (2008) 1399-1401
70. Mueller P.W., Rogus J.J., Cleary P.A., et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. Journal of the American Society of Nephrology 17 7 (2006) 1782-1790
71. Manolio T.A., Rodriguez L.L., Brooks L., et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nature Genetics 39 9 (2007) 1045-1051
72. Karlinger K., Gyorke T., Mako E., Mester A., and Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. European Journal of Radiology 35 3 (2000) 154-167
73. Lashner B.A. Epidemiology of inflammatory bowel disease. Gastroenterology Clinics of North America 24 3 (1995) 467-474
74. Orholm M., Binder V., Sorensen T.I., Rasmussen L.P., and Kyvik K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scandinavian Journal of Gastroenterology 35 10 (2000) 1075-1081
75. Halme L., Paavola-Sakki P., Turunen U., et al. Family and twin studies in inflammatory bowel disease. World Journal of Gastroenterology 12 23 (2006) 3668-3672
76. Bonen D.K., and Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology 124 2 (2003) 521-536
77. Duerr R.H. Update on the genetics of inflammatory bowel disease. Journal of Clinical Gastroenterology 37 5 (2003) 358-367
78. Lazaridis K.N., and Petersen G.M. Genomics, genetic epidemiology, and genomic medicine. Clinical Gastroenterology and Hepatology 3 4 (2005) 320-328
79. Thompson N.P., Driscoll R., Pounder R.E., and Wakefield A.J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312 7023 (1996) 95-96
80. Tysk C., Lindberg E., Jarnerot G., and Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 7 (1988) 990-996
81. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 9518 (2006) 1271-1284
82. Halfvarson J., Bodin L., Tysk C., Lindberg E., and Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124 7 (2003) 1767-1773
83. Satsangi J., Jewell D.P., and Bell J.I. The genetics of inflammatory bowel disease. Gut 40 5 (1997) 572-574
84. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 6837 (2001) 599-603
85. Ogura Y., Bonen D.K., Inohara N., et al. A frame shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 6837 (2001) 603-606
86. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 9272 (2001) 1925-1928
87. Rioux J.D., Daly M.J., Silverberg M.S., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genetics 29 2 (2001) 223-228
88. Mirza M.M., Fisher S.A., King K., et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. American Journal of Human Genetics 72 4 (2003) 1018-1022
89. Peltekova V.D., Wintle R.F., Rubin L.A., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genetics 36 5 (2004) 471-475
90. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 5804 (2006) 1461-1463
91. Baldassano R.N., Bradfield J.P., Monos D.S., et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clinical Gastroenterology and Hepatology 5 8 (2007) 972-976
92. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genetics 39 5 (2007) 596-604
93. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature Genetics 39 2 (2007) 207-211
94. Schmid D., Dengjel J., Schoor O., Stevanovic S., and Munz C. Autophagy in innate and adaptive immunity against intracellular pathogens. Journal of Molecular Medicine 84 3 (2006) 194-202
95. Duerr R.H., Barmada M.M., Zhang L., Pfutzer R., and Weeks D.E. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. American Journal of Human Genetics 66 6 (2000) 1857-1862
96. Hampe J., Schreiber S., Shaw S.H., et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. American Journal of Human Genetics 64 3 (1999) 808-816
97. Shaw S.H., Hampe J., White R., et al. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Human Genetics 113 6 (2003) 514-521
98. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nature Genetics 39 7 (2007) 830-832
99. Baldassano R.N., Bradfield J.P., Monos D.S., et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut 56 8 (2007) 1171-1173
100. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nature Genetics 40 8 (2008) 955-962
101. Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nature Genetics 40 6 (2008) 713-715
102. Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nature Genetics 40 6 (2008) 710-712
103. Franke A., Balschun T., Karlsen T.H., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nature Genetics 40 11 (2008) 1319-1323
104. Silverberg M.S., Cho J.H., Rioux J.D., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nature Genetics (2009)
105. Vernier-Massouille G., Mamadou B., Julia S., et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 135 4 (2008) 1106-1113
106. Van Limbergen J., Russell R.K., Drummond H.E., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135 4 (2008) 1114-1122
107. Kugathasan S., Baldassano R.N., Bradfield J.P., et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nature Genetics 40 10 (2008) 1211-1215
108. Fayad R., Brand M.I., Stone D., Keshavarzian A., and Qiao L. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. European Journal of Immunology 36 8 (2006) 2215-2222
109. Kim S., Fotiadu A., and Kotoula V. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clinical Immunology (Orlando, Fla) 115 3 (2005) 286-294
110. Chang Y.C., Hsu T.L., Lin H.H., et al. Modulation of macrophage differentiation and activation by decoy receptor 3. Journal of Leukocyte Biology 75 3 (2004) 486-494
111. Wortinger M.A., Foley J.W., Larocque P., et al. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology 110 2 (2003) 225-233
112. Moffatt M.F., Kabesch M., Liang L., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448 7152 (2007) 470-473
113. Hirota T., Harada M., Sakashita M., et al. Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. The Journal of Allergy and Clinical Immunology 121 3 (2008) 769-770
114. Galanter J., Choudhry S., Eng C., et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. American Journal of Respiratory and Critical Care Medicine 177 11 (2008) 1194-1200
115. Sleiman P.M., Annaiah K., Imielinski M., et al. ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. The Journal of Allergy and Clinical Immunology 122 6 (2008) 1225-1227
116. Burton P.R., Clayton D.G., Cardon L.R., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 39 11 (2007) 1329-1337
117. Nath S.K., Han S., Kim-Howard X., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nature Genetics 40 2 (2008) 152-154
118. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics 40 2 (2008) 204-210
119. Hom G., Graham R.R., Modrek B., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. The New England Journal of Medicine 358 9 (2008) 900-909
120. Kozyrev S.V., Abelson A.K., Wojcik J., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nature Genetics 40 2 (2008) 211-216
121. Plenge R.M., Seielstad M., Padyukov L., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. The New England Journal of Medicine 357 12 (2007) 1199-1209
122. Behrens E.M., Finkel T.H., Bradfield J.P., et al. Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis. Arthritis and Rheumatism 58 7 (2008) 2206-2207
123. Plenge R.M., Cotsapas C., Davies L., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nature Genetics 39 12 (2007) 1477-1482
124. Barton A., Thomson W., Ke X., et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nature Genetics 40 10 (2008) 1156-1159
125. Raychaudhuri S., Remmers E.F., Lee A.T., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nature Genetics 40 10 (2008) 1216-1223
126. Hafler D.A., Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal of Medicine 357 9 (2007) 851-862
127. Aulchenko Y.S., Hoppenbrouwers I.A., Ramagopalan S.V., et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nature Genetics 40 12 (2008) 1402-1403
128. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Seminars in Immunology 18 4 (2006) 207-213
129. Nejentsev S., Howson J.M., Walker N.M., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 7171 (2007) 887-892